News & Analysis on Clinical Trial Services & Contract Research And Development
Amylin Pharmaceuticals is expanding significantly on the US manufacturing facility it is building in West Chester, Ohio for a long-acting version of its injectable diabetes drug Byetta (exenatide).
Kendle has climbed back into the black in the first quarter of 2007 after another quarter of strong sales although pre-tax profit remains down on 2006.
Indian biopharmaceutical company Wockhardt Limited has continued its push into Europe with the all-cash acquisition of France's Negma Laboratories (Negma-Lerads) for $265m (€195.4m).
The ongoing intellectual property tussle between Pall and Entegris continues with Pall claiming Entegris' Impact filter cartridge line infringes four Pall patents.
Solvay Pharmaceuticals has sold two of its manufacturing facilities that it no longer considers as core. The new owners will now act as a contract manufacturer for Solvay, the company announced today.
An online database detailing information on all manufacturing and importation certificates and authorisations issued within the European medicines network has been launched by the European Medicines Agency (EMEA).
Recently formed Applied Microarrays has rescued GE Healthcare's CodeLink platform and production facility in Tempe, US from closure.
The Biologics division of UK company Avecia has launched pAVEway, a new microbial system for producing high yields of a wide range of therapeutically active protein, such as vaccines, cytokines and growth factors.